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EDITORIAL
Retinoblastoma (RB) is a rare but life-threatening 
condition. If it is managed optimally by a competent 
health team there is an excellent prognosis for life, 
with survival rates of 95% in developed countries. 
Moreover, good visual outcomes are possible.
Kruger et al.[1] in this issue of SAMJ have shown survival rates in a 
region of South Africa (SA) of only 50%, reflecting the high frequency 
of late presentation, the simple reason for which is lack of effective 
screening. Early detection of suspected RB would significantly reduce 
this unacceptably high mortality rate.
Early detection may be achieved by performing a simple clinical 
test on all newborns and toddlers: the red reflex. The red reflex or 
retinal reflex refers to the reddish-orange reflection of light from 
normal retina, and it is observed with a direct ophthalmoscope held 
close to the examiner’s eye, while observing the patient’s eyes from a 
distance of approximately 30 cm. Normally, the reflections of the two 
eyes are equivalent in colour, intensity and clarity. The examiner is 
looking for the presence of a whitening of the reflex, white spots in 
the reflex, an absent red reflex or asymmetry of the two red reflexes 
when viewed from various angles.[2,3]
It is considered standard of care that all newborn babies are tested 
for a red reflex at discharge from the neonatal nursery. Parents are 
similarly able to detect a problem by noticing an abnormality in 
the red reflex in photographs taken when the ‘red eye reduction’ 
function happens to be switched off on their camera. It would not 
be too idealistic to suggest that all doctors attending to neonates and 
toddlers use this humble camera technique and digitally save the red 
reflex images to the patient’s file at each visit.
In the not-too-distant future, neonatal screening will include 
universal digital retinal imaging. The roll-out of diabetic screening 
programmes using portable digital imaging systems is already 
established in many parts of the world, including the Cape Town 
metropole. These systems could be expanded to also serve as 
screening units for neonates.
‘Should eye imaging be part of a standard newborn examin ation?’ 
was the theme of a session presented at the 2014 World Ophthalmol-
ogy Congress of the International Council of Ophthalmology on 3 
April 2014 in Tokyo, Japan. Speakers from the USA, Russia, India, 
China and Taiwan shared their experience with modern retinal 
imaging systems used in universal eye imaging programmes in their 
countries, convincing the audience about the value of such systems in 
neonates. The RetCam (Clarity Medical Systems, USA) is an example 
of a medical device utilising innovative 21st-century optical, electronic 
and information technologies to image the retina of neonates. Its ability 
to perform wide-field imaging on neonatal retinas has revolutionised 
neonatal retinal disease management in the developed world. It has 
been shown to be a safe screening tool when operated by trained 
technicians.[4] Owing to the current cost of this technology, it is not 
yet realistic to propose universal digital retinal imaging of all neonatal 
retinas in SA. However, the development of portable digital retinal 
imaging systems is ongoing, and it will be feasible to screen the retinas 
of all neonates in the future using this technology.
While we were mulling over this editorial, a 3-month-old boy 
presented with bilateral RB. The father had had one eye enucleated 
by us for RB 25 years ago. Patients who were treated decades ago 
may have forgotten that their children are at risk, and they may 
not be aware that genetic testing and/or counselling can now be 
offered. Once a heritable mutation is identified, molecular testing can 
determine which members of a family are at risk of developing RB. 
Children who carry the mutation need to be screened clinically by 
an ophthalmologist 1 week after birth, monthly for 3 months, every 
2 months for 6 months, every 3 months for 2 years and then every 6 
months. This is initially best achieved under general anaesthesia until 
the child is co-operative enough for retinal examination while awake. 
This approach allows for early detection of small tumours. Children 
who do not carry the family’s RB1 mutation are not at increased risk 
and do not require repeated retinal examinations. The benefits and 
cost-effectiveness of genetic screening in affected RB families have 
been well demonstrated.[5]
All the modern ophthalmological treatment modalities for RB 
are available in several centres in SA. For its size and population, SA 
has an adequate number of these tertiary centres and even boasts a 
quaternary centre offering radiation plaque therapy.[6]
Appropriate and timely treatment can be simultaneously curative 
and vision preserving. Since management of a child diagnosed with 
RB requires a multidisciplinary approach, affected children are 
best referred to tertiary/quaternary facilities that provide specialist 
paediatric ophthalmology and oncology services. The various 
provincial departments of health need to co-operate and ensure 
referral of these patients to the existing treatment centres.
As a country we can be proud that our health system has the 
expertise to manage a child with RB well. The issue at stake is timely 
referral of the affected child to one of the specialist treatment centres. 
Our national mortality and morbidity figures for this malignancy 
will only improve if universal eye screening proves successful at 
primary care level.[7,8] Until universal screening with digital imaging 
becomes a reality, the tried-and-trusted, old-fashioned red reflex test 
should be mandatory at discharge from all neonatal services and at all 
subsequent routine health supervision visits. Most RBs would then be 
detected early. An added benefit of compliance with such a screening 
regimen would be the detection of other serious vision-threatening 
disorders such as cataracts, glaucoma and eye muscle imbalances.
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